InvestorsHub Logo

betterdaze

07/18/19 2:47 PM

#8906 RE: onetrade1111 #8905

At least we can still load cheap before liftoff

Goodmooring

07/18/19 2:59 PM

#8907 RE: onetrade1111 #8905

AGREED!! Check out my stickied post from back in March...

The company has a limited financial ability.
They cant get financing because they arent current, which they are currently attempting to get current.
Getting current will give them options for financing.

What i really like about this company is that they arent wasting money by paying for literally anything at this moment.
No employees (Limited Basis Chris Lowe)
No office space
No overhead
All board members are working/studying at other facilities:
https://www.investing.businessweek.wallst.com/research/stocks/people/board.asp?ticker=NSPX

They own the drug Patents.
The are letting others help in the study and advancement through University/Government Grants. Anything they come up with is owned under the Patents

They are not throwing money away.
No money wasted on PR's.

They only information coming out about their Orphan Status DRUG $MIPSAGARGIN is PUBLISHED via FACTUAL PIER REVIEWED Scientific Communities.

When they solve the Synthesized Mipsagargin hold up and are able to commercially provide a viable supply chain that is going to be the catalyst for PHASE 3 Clinical Trials!

flaflyersfan

07/18/19 5:22 PM

#8908 RE: onetrade1111 #8905

onetrade1111, it is because business does not matter on penny stocks;

People make the mistake that real business and revenues and profits matter and think that their stock is better because of it.

Your example is proof that business does not matter. Penny stocks are popularity contests. Nothing more; nothing less.

Good luck.